
Polycystic Ovarian Syndrome (PCOS)
Polycystic ovary syndrome (PCOS) is a common condition that affects how a woman's ovaries work.
The 3 main features of PCOS are:
- irregular periods – which means your ovaries do not regularly release eggs (ovulation)
- excess androgen – high levels of "male" hormones in your body, which may cause physical signs such as excess facial or body hair
- polycystic ovaries – your ovaries become enlarged and contain many fluid-filled sacs (follicles) that surround the eggs (but despite the name, you do not actually have cysts if you have PCOS)
If you have at least 2 of these features, you may be diagnosed with PCOS.

Q10
After adjustment for potential confounders, supplementation with CoQ10 alone or in combination with vitamin E, compared with placebo, had significant effects on fasting blood sugar (FBS); vitamin E's effect on FBS was not significant. A significant reduction in homeostasis model assessment of insulin resistance (HOMA-IR) was observed in the CoQ10 and combined groups. CoQ10, vitamin E, and co-supplementation led to decreased serum total testosterone levels (P < 0.001) compared with those of the placebo group. CoQ10 supplementation in combination with vitamin E significantly improved in sex hormone-binding globulin (SHBG) levels compared with other groups (P = 0.008). Linear regression analysis revealed that changes in FBS, insulin, and HOMA-IR were predictors of change in free androgen index (P < 0.05).
Conclusion: CoQ10 with or without vitamin E supplementation among women with PCOS had beneficial effects on serum FBS and insulin levels, as well as HOMA-IR and total testosterone levels. However, only co-supplementation affected SHBG concentrations.
J Clin Endocrinol Metab . 2019 Feb 1;104(2):319-327. doi: 10.1210/jc.2018-01221.
A-lipoic acid
The aim of this retrospective study was to evaluate the effects of a treatment with α-lipoic acid (ALA) associated with two different doses of myo-inositol (MI) on clinical and metabolic features of women with polycystic ovary syndrome (PCOS). Eighty-eight women received the treatment, and 71 among them had complete clinical charts and were considered eligible for this study. All women were treated with 800 mg of ALA per day: 43 patients received 2000 mg of MI and 28 received 1000 mg of MI per day. In conclusion, ALA + MI positively affects the menstrual regularity of women with PCOS, regardless of their metabolic phenotype, with a more evident effect with a higher dose of MI. This effect seems to be insulin independent.
International Journal of Endocrinology, Volume 2020 | Article ID 2901393 | https://doi.org/10.1155/2020/2901393
Over the past decade, integrative treatments using inositols and alpha lipoic acid have been proposed and reported to be greatly effective on the dysmetabolic aspects of PCOS. In addition, these integrative treatments have been demonstrated to be greatly effective especially in PCOS patients who are overweight/obese and have a familial predisposition to diabetes.
GREM, 03/2020, Review , 146-157, DOI: doi.org/10.53260/GREM.201033
Content coming soon
** All data above are published as clinical trials and do not refer to EFSA claims. This means that they do not intend to be medical or therapeutical advice.